US Stocks
/
Crescent Biopharma, Inc. Share Price
Crescent Biopharma, Inc. Share Price

Crescent Biopharma, Inc. Share Price

NASDAQ: CBIO
$14.10
+$0.54 (3.98%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Crescent Biopharma, Inc. Stock Performance

Open
$13.10
Prev. Close
$13.56
Circuit Range
N/A
Day Range
$13.10 - $14.52
Year Range
$8.81 - $27.41
Volume
9,184
Average Traded
$13.95

Crescent Biopharma, Inc. Share Price Today

As of 9 October 2026, Crescent Biopharma, Inc.'s share price is $14.10. The stock opened at $13.10, compared to its previous close of $13.56. During today's trading session, Crescent Biopharma, Inc.'s share price traded between $13.10 and $14.52, with an average price of $13.81. Over the past 52 weeks, the stock has recorded a high of $27.41 and a low of $8.81. In terms of performance, Crescent Biopharma, Inc.'s share price has declined by 36.79% over the last six months and is up 10.81% on a year-on-year basis.

Crescent Biopharma, Inc. Share Price Chart

$13.10$14.52
L
Show Current Price
H

Crescent Biopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.93
Revenue (TTM)
$10.84B
Return On Equity (TTM)
-89.40%
Profit Margin
-1231.09%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-8.31%

Crescent Biopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$10.84$1.04$0.00
Net Profit-$20.95-$81.06-$21.26-$22.69
Net Profit MarginN/A-747.79%-2044.23%N/A
Income ChangeN/A-286.92%73.77%-6.73%

Crescent Biopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars20222025
Revenue$102.29$10.84
Net Profit$2.30-$133.45
Net Profit Margin2.25%-1231.09%
Income ChangeN/A-5902.17%

About Crescent Biopharma, Inc.

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. The company focuses on advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

Crescent Biopharma, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$14.48
$14.18
-3.93%
Sep 2026
$16.50
$14.76
-18.66%
Aug 2026
$14.59
$18.14
+25.62%
Jul 2026
$17.91
$14.44
-19.62%
Jun 2026
$19.60
$17.96
-12.60%
May 2026
$20.53
$20.55
-7.85%
Apr 2026
$18.83
$22.30
+21.32%
Mar 2026
$11.75
$18.39
+51.19%
Feb 2026
$9.89
$12.16
+27.20%
Jan 2026
$11.51
$9.56
-19.05%
Dec 2025
$14.57
$11.81
-22.51%
Nov 2025
$12.51
$15.24
+19.76%

CBIO Share Price FAQs

What is Crescent Biopharma, Inc. share price today?

chevron-up
Crescent Biopharma, Inc. share price today is $14.10 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Crescent Biopharma, Inc. stock?

chevron-up
The 52 week high of Crescent Biopharma, Inc. stock is $27.41, while the 52 week low is $8.81 as of 9 Oct '26.

What is CBIO's net income for the last quarter?

chevron-up
CBIO's net income for the last quarter is -22.69B USD.

What is the 5 year returns of CBIO?

chevron-up
The 5 year returns of CBIO is -99.50% as on 9 Oct '26.

What is the high & low stock price of CBIO today?

chevron-up
CBIO stock price hit a high of $14.52 and low of $13.10 as of 9 Oct '26.

Can I buy CBIO shares in India?

chevron-up
Yes. You can buy CBIO in India by opening an international trading account.